Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography
Watanabe, H.; Kaiho, H.; Takahashi, H.; Kato, T.; Shima, M.
Hinyokika Kiyo. Acta Urologica Japonica 16(9): 438-445
1970
ISSN/ISBN: 0018-1994 PMID: 4097357 Document Number: 20342
Document emailed within 1 workday
Related Documents
Suzuki, K.; Ichinose, Y.; Hashimoto, K.; Matsumoto, K.; Suzuki, T.; Imai, K.; Yamanaka, H. 1990: Clinical studies on morphological changes in the prostate in patients with benign prostatic hypertrophy after antiandrogen therapy--by means of transrectal ultrasonotomography Hinyokika Kiyo. Acta Urologica Japonica 36(5): 557-560Yamada, S.; Ashizawa, N.; Ushijima, H.; Nakayama, K.; Hayashi, E.; Honda, K. 1987: Alpha-1 adrenoceptors in human prostate: characterization and alteration in benign prostatic hypertrophy Journal of Pharmacology and Experimental Therapeutics 242(1): 326-330
Martin, A.A.; Clejan, S. 1994: Prostate specific antigen density: a method for differentiating prostate carcinoma from benign prostatic hypertrophy demonstrates ethnic variation Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 146(4): 163-171
Takeda, M.; Takagi, T. 1980: Effects of a new bronchodilator, (alpha RS)-3-formamido-4-hydroxy-alpha-[[[(alpha RS)-p-methoxy-alpha-methylphenethyl] amino] methyl] benzyl alcohol fumarate dihydrate (BD 40A) on gastric acid secretion and gastrointestinal motility Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 76(3): 185-191
Porter, R.S.; Young, K.; Bahr, R.J. 1984: What is your diagnosis? Hypertrophy of the prostate and calcified prostatic cyst Journal of the American Veterinary Medical Association 185(7): 807-808
Verlooy, J.; van Sande, M.; Van Camp, K. 1980: Aldolase activity in benign prostatic hypertrophy and adenocarcinomatous prostate Acta Urologica Belgica 48(1): 65-67
Leus, R.; van Sande, M.; Van Camp, K. 1981: Isocitrate dehydrogenase activity in untreated and treated benign prostatic hypertrophy and adenocarcinomatous prostate Acta Urologica Belgica 49(1): 61-63
Kato, Y.; Nakata, S.; Sato, J.; Mayuzumi, T.; Shimizu, T. 1996: A case of prostate cancer diagnosed one and half year after retropubic prostatectomy for benign prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 42(11): 907-909
Levtchenko, N.K.; Osokin, D.M.; Torgov, I.V.; Arzamastzev, A.P.; Sokolova, T.M.; Tuguntaev, G.I. 1988: High-performance liquid chromatographic analysis of the by-products of the synthesis of ethynylestradiol, mestranol, 17 alpha-hydroxy-progesterone caproate and 17 alpha-hydroxy-6-dehydroprogesterone acetate Journal of Chromatography 456(2): 427-430
Ishizawa, K.; Murai, K.; Kimura, S.; Matsuoka, J.; Chin, M. 1974: Comparative study of vectorcardiography and radiocardiography - with special reference to left ventricular hypertrophy Nihon Rinsho. Japanese Journal of Clinical Medicine 32(9): 3004-3006
Kohri, K.; Kurita, T.; Iguchi, M.; Kataoka, K. 1986: Clinical effects of allylestrenol on prostatic hypertrophy Hinyokika Kiyo. Acta Urologica Japonica 32(3): 486-492
Hansen, B.J.; Hvidt, V. 1993: Finasteride. a new 5 alpha reductase inhibitor registered for treatment of benign prostatic hypertrophy with the purpose of avoiding or postponing surgery Ugeskrift for Laeger 155(50): 4110-4112
Matzkin, H.; Chayen, R.; Goldfarb, H.; Gilad, S.; Braf, Z. 1992: Laboratory monitoring of androgenic activity in benign prostate hypertrophy treated with a 5 alpha-reductase inhibitor Clinical Chemistry 38(7): 1304-1306
Hermieu, J.F.; Ravery, V.; Le Coent, R.; Delmas, V.; Boccon-Gibod, L. 1998: Effects of a 6F urethral catheter on uroflowmetry in men with benign prostatic hypertrophy Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 8(6): 1035-1038
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Yamada, S.; Fukuhara, T.; Fukuda, Y.; Matsuzaki, K.; Yoshinare, T. 1975: Experimental study of hemorrhagic shock - with special reference to estimation of left ventricular function by thermodilution method Masui. Japanese Journal of Anesthesiology 24(12): 1227-1234
Begani, R. 1974: Case of retro-caval ureter with special reference to current means of study and surgical treatment Minerva Pediatrica 26(30): 1506-1509
Schubert, G.E.; Ziegler, H.; Völter, D. 1973: Comparison of histological and cytological studies of the prostate with special reference to oestrogene induced changes Verhandlungen der Deutschen Gesellschaft für Pathologie 57: 315-318
Tanno, T. 1992: Experimental study on the spinal lesions in hyperostotic mouse (twy/twy): special reference to the pathogenesis of the ossification of the spinal ligaments and to the action of ethane-1-hydroxy-1, 1-diphosphonate (EHDP) Nihon Seikeigeka Gakkai Zasshi 66(10): 1073-1083
Pisani, E. 1995: Multicenter clinical study of the effects of once daily administration of mepartricin 150.000 U. in benign prostatic hypertrophy Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 67(4): 223-230